BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Sina Fuchs, Monika Bayer, Richard Taubert, Michael P. Manns, Josef M. Pfeilschifter, Urs Christen, Edith Hintermann. Effects of adenovirus‐induced hepatocyte damage on chronic bile duct inflammation in a sclerosing cholangitis mouse modelLiver International 2019; 39(12): 2330 doi: 10.1111/liv.14183
2
Manoj Thapa, Dana Tedesco, Sanjeev Gumber, Elizabeth J. Elrod, Jin-Hwan Han, William H. Kitchens, Joseph F. Magliocca, Andrew B. Adams, Arash Grakoui. Blockade of BAFF Reshapes the Hepatic B Cell Receptor Repertoire and Attenuates Autoantibody Production in Cholestatic Liver DiseaseThe Journal of Immunology 2020; 204(12): 3117 doi: 10.4049/jimmunol.1900391
3
D. Robert Dufour. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics2012; : 1637 doi: 10.1016/B978-1-4160-6164-9.00050-0
4
Kazuhito Kawata, Yoshimasa Kobayashi, M. Eric Gershwin, Christopher L. Bowlus. The Immunophysiology and Apoptosis of Biliary Epithelial Cells: Primary Biliary Cirrhosis and Primary Sclerosing CholangitisClinical Reviews in Allergy & Immunology 2012; 43(3): 230 doi: 10.1007/s12016-012-8324-0
5
John E. Eaton, Jayant A. Talwalkar, Keith D. Lindor. The Autoimmune Diseases2014; : 925 doi: 10.1016/B978-0-12-384929-8.00063-0
6
Evaggelia Liaskou, Gideon M. Hirschfield, M. Eric Gershwin. Mechanisms of tissue injury in autoimmune liver diseasesSeminars in Immunopathology 2014; 36(5): 553 doi: 10.1007/s00281-014-0439-3
7
Sebastian Torben Jendrek, Daniel Gotthardt, Thomas Nitzsche, Laila Widmann, Tobias Korf, Maike Anna Michaels, Karl-Heinz Weiss, Evaggelia Liaskou, Mette Vesterhus, Tom Hemming Karlsen, Swantje Mindorf, Peter Schemmer, Florian Bär, Bianca Teegen, Torsten Schröder, Marc Ehlers, Christoph Matthias Hammers, Lars Komorowski, Hendrik Lehnert, Klaus Fellermann, Stefanie Derer, Johannes Roksund Hov, Christian Sina. Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitisGut 2017; 66(1): 137 doi: 10.1136/gutjnl-2016-311739
8
José Franco. Liver Disorders2017; : 289 doi: 10.1007/978-3-319-30103-7_17
9
Claudia O. Zein, Keith D. Lindor. Latest and Emerging Therapies for Primary Biliary Cirrhosis and Primary Sclerosing CholangitisCurrent Gastroenterology Reports 2010; 12(1): 13 doi: 10.1007/s11894-009-0079-2
10
Matteo Bramuzzo, Stefano Martelossi, Giuliano Torre, Sabrina Cardile, Serena Arrigo, Silvia Vignola, Federica Ferrari, Giovanna Zuin, Maria Teresa Illiceto, Marco Gasparetto, Salvatore Pellegrino, Claudio Romano, Giuseppe Maggiore, Marcella Montico, Marina Aloi. Clinical Features and Risk Factors of Autoimmune Liver Involvement in Pediatric Inflammatory Bowel DiseaseJournal of Pediatric Gastroenterology and Nutrition 2016; 63(2): 259 doi: 10.1097/MPG.0000000000001078
11
José Franco. Pancreas and Biliary Disease2016; : 321 doi: 10.1007/978-3-319-28089-9_14
12
Marcial Sebode, Christina Weiler-Normann, Timur Liwinski, Christoph Schramm. Autoantibodies in Autoimmune Liver Disease—Clinical and Diagnostic RelevanceFrontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.00609
13
Kirsten Muri Boberg, Roger W. Chapman, Gideon M. Hirschfield, Ansgar W. Lohse, Michael P. Manns, Erik Schrumpf. Overlap syndromes: The International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issueJournal of Hepatology 2011; 54(2): 374 doi: 10.1016/j.jhep.2010.09.002
14
“Autoimmune(-Like)” Drug and Herb Induced Liver Injury: New Insights into Molecular PathogenesisInternational Journal of Molecular Sciences 2017; 18(9): 1954 doi: 10.3390/ijms18091954
15
A. Schreiber, B. Rudolph, A. Kahl, R. Kettritz. Akutes Nierenversagen bei einem lebertransplantierten PatientenDer Nephrologe 2015; 10(5): 416 doi: 10.1007/s11560-014-0932-7
16
Brian K. Chung, Gideon M. Hirschfield. Immunogenetics in primary sclerosing cholangitisCurrent Opinion in Gastroenterology 2017; 33(2): 93 doi: 10.1097/MOG.0000000000000336
17
Tom H. Karlsen, Trine Folseraas, Douglas Thorburn, Mette Vesterhus. Primary sclerosing cholangitis – a comprehensive reviewJournal of Hepatology 2017; 67(6): 1298 doi: 10.1016/j.jhep.2017.07.022
18
Shou-Pei Liu, Zhen-Hua Bian, Zhi-Bin Zhao, Jinjun Wang, Weici Zhang, Patrick S.C. Leung, Liang Li, Zhe-Xiong Lian. Animal Models of Autoimmune Liver Diseases: a Comprehensive ReviewClinical Reviews in Allergy & Immunology 2020; 58(2): 252 doi: 10.1007/s12016-020-08778-6
19
Elisabeth M.G. de Vries, Ulrich Beuers, Cyriel Y. Ponsioen. Biomarkers for disease progression of primary sclerosing cholangitisCurrent Opinion in Gastroenterology 2015; 31(3): 239 doi: 10.1097/MOG.0000000000000163
20
Hiroyuki Isayama, Susumu Tazuma, Norihiro Kokudo, Atsushi Tanaka, Toshio Tsuyuguchi, Takahiro Nakazawa, Kenji Notohara, Suguru Mizuno, Nobuhisa Akamatsu, Masahiro Serikawa, Itaru Naitoh, Yoshiki Hirooka, Toshifumi Wakai, Takao Itoi, Tomoki Ebata, Shinji Okaniwa, Terumi Kamisawa, Hiroki Kawashima, Atsushi Kanno, Keiichi Kubota, Masami Tabata, Michiaki Unno, Hajime Takikawa. Clinical guidelines for primary sclerosing cholangitis 2017Journal of Gastroenterology 2018; 53(9): 1006 doi: 10.1007/s00535-018-1484-9
21
Xiaojun Jiang, Tom H. Karlsen. Genetics of primary sclerosing cholangitis and pathophysiological implicationsNature Reviews Gastroenterology & Hepatology 2017; 14(5): 279 doi: 10.1038/nrgastro.2016.154
22
Benedetta Terziroli Beretta‐Piccoli, Giorgina Mieli‐Vergani, Diego Vergani. Autoimmune Liver Disease2020; : 65 doi: 10.1002/9781119532637.ch4
23
Takuma Misawa, Jeffrey A. SoRelle, Jin Huk Choi, Tao Yue, Kuan-wen Wang, William McAlpine, Jianhui Wang, Aijie Liu, Koichi Tabeta, Emre E. Turer, Bret Evers, Evan Nair-Gill, Subhajit Poddar, Lijing Su, Feiya Ou, Liyang Yu, Jamie Russell, Sara Ludwig, Xiaoming Zhan, Sara Hildebrand, Xiaohong Li, Miao Tang, Anne R. Murray, Eva Marie Y. Moresco, Bruce Beutler. Mutual inhibition between Prkd2 and Bcl6 controls T follicular helper cell differentiationScience Immunology 2020; 5(43): eaaz0085 doi: 10.1126/sciimmunol.aaz0085
24
Kelly Hudspeth, Elena Pontarini, Paolo Tentorio, Matteo Cimino, Matteo Donadon, Guido Torzilli, Enrico Lugli, Silvia Della Bella, M. Eric Gershwin, Domenico Mavilio. The role of natural killer cells in autoimmune liver disease: A comprehensive reviewJournal of Autoimmunity 2013; 46: 55 doi: 10.1016/j.jaut.2013.07.003
25
Priscila Menezes Ferri, Ana Cristina Simões e Silva, Soraya Luiza Campos Silva, Diego Junior Queiroga de Aquino, Eleonora Druve Tavares Fagundes, Débora Marques de Miranda, Alexandre Rodrigues Ferreira. The Role of Genetic and Immune Factors for the Pathogenesis of Primary Sclerosing Cholangitis in ChildhoodGastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/3905240
26
U. Spengler. Differenzialdiagnose IkterusDer Gastroenterologe 2010; 5(4): 363 doi: 10.1007/s11377-009-0390-3
27
Paola De Angelis, Renato Tambucci, Erminia Romeo, Francesca Rea, Claudia Caloisi, Tamara Caldaro, Giovanni Federici di Abriola, Francesca Foschia, Filippo Torroni, L. Monti, Luigi Dall'Oglio. Does an isolated benign choledochal stricture hide a PSC?Journal of Pediatric Surgery 2013; 48(5): 1006 doi: 10.1016/j.jpedsurg.2013.02.020
28
Christopher L. Bowlus. Liver Immunology2014; : 45 doi: 10.1007/978-3-319-02096-9_4
29
Shikib Mostamand, Shauna Schroeder, Jacqueline Schenkein, Tamir Miloh. Infliximab-Associated Immunomediated Hepatitis in Children With Inflammatory Bowel DiseaseJournal of Pediatric Gastroenterology & Nutrition 2016; 63(1): 94 doi: 10.1097/MPG.0000000000001137
30
Lena Berglin, Niklas K. Björkström, Annika Bergquist. Primary sclerosing cholangitis is associated with autoreactive IgA antibodies against biliary epithelial cellsScandinavian Journal of Gastroenterology 2013; 48(6): 719 doi: 10.3109/00365521.2013.786131
31
T. Liwinski, C. Schramm. Primär sklerosierende CholangitisDer Internist 2018; 59(6): 551 doi: 10.1007/s00108-018-0428-z
32
Johannes R. Hov, Kirsten M. Boberg, Eli Taraldsrud, Mette Vesterhus, Maria Boyadzhieva, Inger Camilla Solberg, Erik Schrumpf, Morten H. Vatn, Benedicte A. Lie, Øyvind Molberg, Tom H. Karlsen. Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitisLiver International 2017; 37(3): 458 doi: 10.1111/liv.13238
33
Abin Chandrakumar, Rachael Loeppky, Mark Deneau, Wael El-Matary. Inflammatory Bowel Disease in Children with Elevated Serum Gamma Glutamyltransferase LevelsThe Journal of Pediatrics 2019; 215: 144 doi: 10.1016/j.jpeds.2019.07.065
34
Rodrigo Liberal, Giorgina Mieli-Vergani, Diego Vergani. Clinical significance of autoantibodies in autoimmune hepatitisJournal of Autoimmunity 2013; 46: 17 doi: 10.1016/j.jaut.2013.08.001
35
Erik Schrumpf, Kirsten Muri Boberg, Tom H. Karlsen. Primary sclerosing cholangitis – the Norwegian experienceScandinavian Journal of Gastroenterology 2015; 50(6): 781 doi: 10.3109/00365521.2015.1028996
36
Channakeshava Sokke Umeshappa, Santiswarup Singha, Jesus Blanco, Kun Shao, Roopa Hebbandi Nanjundappa, Jun Yamanouchi, Albert Parés, Pau Serra, Yang Yang, Pere Santamaria. Suppression of a broad spectrum of liver autoimmune pathologies by single peptide-MHC-based nanomedicinesNature Communications 2019; 10(1) doi: 10.1038/s41467-019-09893-5
37
John M. Vierling. Primary Sclerosing Cholangitis2017; : 111 doi: 10.1007/978-3-319-40908-5_9
38
Rosebella A. Iseme, Mark McEvoy, Brian Kelly, Linda Agnew, Frederick R. Walker, Michael Boyle, John Attia. A Cross-Sectional Study of the Association between Autoantibodies and Qualitative Ultrasound Index of Bone in an Elderly Sample without Clinical Autoimmune DiseaseJournal of Immunology Research 2018; 2018: 1 doi: 10.1155/2018/9407971
39
Claudia O. Zein. Primary Sclerosing CholangitisClinics in Liver Disease 2013; 17(2): 211 doi: 10.1016/j.cld.2012.11.003
40
C. Buffet. Cholangites sclérosantesEMC - Hépatologie 2011; 6(1): 1 doi: 10.1016/S1155-1976(11)50375-4
41
Sergey Moiseev, Jan Willem Cohen Tervaert, Yoshihiro Arimura, Dimitrios P. Bogdanos, Elena Csernok, Jan Damoiseaux, Marc Ferrante, Luis Felipe Flores-Suárez, Marvin J. Fritzler, Pietro Invernizzi, David Jayne, J. Charles Jennette, Mark A. Little, Stephen P. McAdoo, Pavel Novikov, Charles D. Pusey, Antonella Radice, Alan D. Salama, Judith A. Savige, Mårten Segelmark, Yehuda Shoenfeld, Renato A. Sinico, Maria-José Sousa, Ulrich Specks, Benjamin Terrier, Athanasios G. Tzioufas, Severine Vermeire, Ming-Hui Zhao, Xavier Bossuyt. 2020 international consensus on ANCA testing beyond systemic vasculitisAutoimmunity Reviews 2020; 19(9): 102618 doi: 10.1016/j.autrev.2020.102618
42
Kirsten Muri Boberg. Autoimmune Hepatitis2012; : 217 doi: 10.1007/978-1-60761-569-9_12
43
Pietro Invernizzi. Geoepidemiology of autoimmune liver diseasesJournal of Autoimmunity 2010; 34(3): J300 doi: 10.1016/j.jaut.2009.12.002
44
EASL Clinical Practice Guidelines: Management of cholestatic liver diseasesJournal of Hepatology 2009; 51(2): 237 doi: 10.1016/j.jhep.2009.04.009
45
Sarajo Kumar Mohanta, Changjun Yin, Li Peng, Prasad Srikakulapu, Vineela Bontha, Desheng Hu, Falk Weih, Christian Weber, Norbert Gerdes, Andreas J.R. Habenicht. Artery Tertiary Lymphoid Organs Contribute to Innate and Adaptive Immune Responses in Advanced Mouse AtherosclerosisCirculation Research 2014; 114(11): 1772 doi: 10.1161/CIRCRESAHA.114.301137
46
Keisuke Kakisaka, Kazuyuki Ishida, Kojiro Kataoka, Yuji Suzuki, Shunichi Yanai, Hidekatsu Kuroda, Tamotsu Sugai, Takayuki Matsumoto, Yasuhiro Takikawa. Reversible sclerosing cholangitis with ulcerative colitisPathology International 2016; 66(7): 404 doi: 10.1111/pin.12427
47
Haiyan Zhang, Patrick S.C. Leung, M. Eric Gershwin, Xiong Ma. How the biliary tree maintains immune tolerance?Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(4): 1367 doi: 10.1016/j.bbadis.2017.08.019
48
Brian K. Chung, Bardia T. Guevel, Gary M. Reynolds, D.B.R.K. Gupta Udatha, Eva Kristine Klemsdal Henriksen, Zania Stamataki, Gideon M. Hirschfield, Tom Hemming Karlsen, Evaggelia Liaskou. Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitisJournal of Autoimmunity 2017; 77: 45 doi: 10.1016/j.jaut.2016.10.003
49
K. Wiencke, K.M. Boberg. Current consensus on the management of primary sclerosing cholangitisClinics and Research in Hepatology and Gastroenterology 2011; 35(12): 786 doi: 10.1016/j.clinre.2011.04.007
50
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani. Serology in autoimmune hepatitis: A clinical-practice approachEuropean Journal of Internal Medicine 2018; 48: 35 doi: 10.1016/j.ejim.2017.10.006
51
Piotr Milkiewicz, Marcin Krawczyk, Ewa Wunsch, Cyriel Ponsioen, Gideon M. Hirschfield, Stefan G. Hubscher. Primary Sclerosing Cholangitis With Features of Autoimmune Hepatitis: Exploring the Global Variation in ManagementHepatology Communications 2020; 4(3): 399 doi: 10.1002/hep4.1467
52
Sang-Heum Park, Hoo Rim Song, Sung Won Lee, Tae Hoon Lee. Wouldn't Human Understanding be Necessary to Treat Patients with Pancreaticobiliary Disease More Effectively?The Korean Journal of Pancreas and Biliary Tract 2018; 23(3): 89 doi: 10.15279/kpba.2018.23.3.89
53
Nathalie Pena Polanco, Claudia Cottone, Kalyan Ram Bhamidimarri. PSC and Overlap SyndromesCurrent Hepatology Reports 2020; 19(2): 106 doi: 10.1007/s11901-020-00518-w
54
Jason B. Samarasena, Ke-Qin Hu. Hepatobiliary Manifestations of Gastrointestinal and Nutritional DisordersClinics in Liver Disease 2011; 15(1): 89 doi: 10.1016/j.cld.2010.09.003
55
P. J. Trivedi, G. M. Hirschfield. Review article: overlap syndromes and autoimmune liver diseaseAlimentary Pharmacology & Therapeutics 2012; 36(6): 517 doi: 10.1111/j.1365-2036.2012.05223.x
56
Roger Chapman, Johan Fevery, Anthony Kalloo, David M. Nagorney, Kirsten Muri Boberg, Benjamin Shneider, Gregory J. Gores. Diagnosis and management of primary sclerosing cholangitisHepatology 2010; 51(2): 660 doi: 10.1002/hep.23294
57
Samar H. Ibrahim, Keith D. Lindor. Current Management of Primary Sclerosing Cholangitis in Pediatric PatientsPediatric Drugs 2011; 13(2): 87 doi: 10.2165/11586500-000000000-00000
58
Elisabeth Krones, Ivo Graziadei, Michael Trauner, Peter Fickert. Evolving concepts in primary sclerosing cholangitisLiver International 2011; : n/a doi: 10.1111/j.1478-3231.2011.02607.x
59
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani. The clinical usage and definition of autoantibodies in immune-mediated liver disease: A comprehensive overviewJournal of Autoimmunity 2018; 95: 144 doi: 10.1016/j.jaut.2018.10.004
60
Tom H. Karlsen, Erik Schrumpf, Kirsten M. Boberg. Update on primary sclerosing cholangitisDigestive and Liver Disease 2010; 42(6): 390 doi: 10.1016/j.dld.2010.01.011
61
Sigrid Næss, Alexey Shiryaev, Johannes R. Hov, Andre Franke, Tom H. Karlsen. Genetics in primary sclerosing cholangitisClinics and Research in Hepatology and Gastroenterology 2012; 36(4): 325 doi: 10.1016/j.clinre.2012.02.003
62
Krisztina Hagymási, Zsolt Tulassay. Review of overlap syndromes of autoimmune liver diseases. Difficulties in the diagnosis and treatmentOrvosi Hetilap 2013; 154(24): 923 doi: 10.1556/OH.2013.29640
63
Klaus Felix, Oliver Hauck, Martina Schnölzer, Tore Kempf, Uwe Warnken, Kathrin Schneider, Frank Bergmann, Stefan Fritz, Jens Werner. Identification of Novel Serum Autoantibodies for Differential Diagnosis of Autoimmune Pancreatitis and Pancreatic Ductal AdenocarcinomaPancreas 2016; 45(9): 1309 doi: 10.1097/MPA.0000000000000647
64
Tom Hemming Karlsen, Kirsten Muri Boberg. Sherlock's Diseases of the Liver and Biliary System2018; : 341 doi: 10.1002/9781119237662.ch18
65
Brian K. Chung, Eva Kristine Klemsdal Henriksen, Kristin Kaasen Jørgensen, Tom H. Karlsen, Gideon M. Hirschfield, Evaggelia Liaskou. Gut and Liver B Cells of Common Clonal Origin in Primary Sclerosing Cholangitis–Inflammatory Bowel DiseaseHepatology Communications 2018; 2(8): 960 doi: 10.1002/hep4.1200
66
Senka Dobric, Dragan Popovic, Milos Nikolic, Sladjana Andrejevic, Milan Spuran, Branka Bonaci-Nikolic. Anti-neutrophil cytoplasmic antibodies (ANCA) specific for one or several antigens: useful markers for subtypes of ulcerative colitis and associated primary sclerosing cholangitisClinical Chemistry and Laboratory Medicine 2012; 50(3) doi: 10.1515/cclm.2011.797
67
Simona Marzorati, Pietro Invernizzi, Ana Lleo. Making Sense of Autoantibodies in Cholestatic Liver DiseasesClinics in Liver Disease 2016; 20(1): 33 doi: 10.1016/j.cld.2015.08.003
68
Albert Parés. Colangitis esclerosante primaria: diagnóstico, pronóstico y tratamientoGastroenterología y Hepatología 2011; 34(1): 41 doi: 10.1016/j.gastrohep.2010.02.006
69
Biljana Radovanović-Dinić, Snežana Tešić-Rajković, Valentina Zivkovic, Saša Grgov. Clinical connection between rheumatoid arthritis and liver damageRheumatology International 2018; 38(5): 715 doi: 10.1007/s00296-018-4021-5
70
Tom Hemming Karlsen, Gideon M. Hirschfield. Primary Sclerosing Cholangitis2017; : 99 doi: 10.1007/978-3-319-40908-5_8
71
Naomi Richardson, Sky T. H. Ng, David C. Wraith. Antigen-Specific Immunotherapy for Treatment of Autoimmune Liver DiseasesFrontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.01586
72
Hanh D. Vo, Jiliu Xu, Simon S. Rabinowitz, Stanley E. Fisher, Steven M. Schwarz. The Liver in Pediatric Gastrointestinal DiseaseJournal of Pediatric Gastroenterology and Nutrition 2014; 59(3): 288 doi: 10.1097/MPG.0000000000000444
73
Ban-Hock Toh. Diagnostic autoantibodies for autoimmune liver diseasesClinical & Translational Immunology 2017; 6(5): e139 doi: 10.1038/cti.2017.14
74
Antonio Di Sabatino, Federico Biagi, Marco Lenzi, Luca Frulloni, Marco Vincenzo Lenti, Paolo Giuffrida, Gino Roberto Corazza. Clinical usefulness of serum antibodies as biomarkers of gastrointestinal and liver diseasesDigestive and Liver Disease 2017; 49(9): 947 doi: 10.1016/j.dld.2017.06.010
75
Verghese George, Varaha Sairam Tammisetti, Venkateswar Rao Surabhi, Alampady K. Shanbhogue. Chronic Fibrosing Conditions in Abdominal ImagingRadioGraphics 2013; 33(4): 1053 doi: 10.1148/rg.334125081
76
Henrike Lenzen, Tobias J. Weismüller, Ahmed A. Negm, Jenny Wlecke, Stephanie Loges, Christian P. Strassburg, Michael P. Manns, Tim O. Lankisch. Antineutrophil cytoplasmic antibodies in bile are associated with disease activity in primary sclerosing cholangitisScandinavian Journal of Gastroenterology 2013; 48(10): 1205 doi: 10.3109/00365521.2013.825313
77
E V Vinnitskaya, S R Abdulkhakov, D T Abdurakhmanov, R B Alikhanov, I G Bakulin, E A Belousova, A O Bueverov, E Z Burnevitch, M G Efanov, E Yu Eremina, T M Ignatova, L Yu Ilchenko, G G Karmazanovsky, O V Knyazev, Yu V Kulezneva, T N Lopatkina, T P Nekrasova, I G Nikitin, V V Pavlenko, A I Parfenov, S D Podymova, K L Raichelson, A R Reisis, R G Sayfutdinov, E V Skazyvaeva, V E Syutkin, S G Khomeriki, T Yu Haimenova, Yu G Sandler. Important problems in the diagnosis and treatment of primary sclerosing cholangitis (based on the Russian consensus on diagnosis and treatment autoimmune hepatitis. Moscow, 2018)Terapevticheskii arkhiv 2019; 91(2): 9 doi: 10.26442/00403660.2019.02.000075